Emerging therapeutic strategies in autoimmune diabetes: aetiology, prediction, prevention and cure

Bibliography

• GEPTS W: Pathological anatomy of the pancreas in ju-venile diabetes mellitus. Diabetes (1965) 14:619–633.
   PubMed Web of Science ®Google Scholar
• Report of the expert committee on the diagnosis andclassification of diabetes mellitus. Diabetes Care (1997) 20:1183–97.
   PubMedGoogle Scholar
• LANDIN-OLSSON M, KARLSSON A, DAHLQUIST G et al.: Is-let cell and other organ-specific auto-antibodies in children developing Type I (insulin-dependent) diabe-tes mellitus in Sweden during one year and in matched control children. Diabetologia (1989) 32:387–395.
   PubMed Web of Science ®Google Scholar
• DAVIES JL, KAWAGUCHI Y, BENNETT ST et al.: A genome-wide search for human Type 1 diabetes sus-ceptibility genes. Nature (1994) 371:130–136.
   PubMed Web of Science ®Google Scholar
• ••Two major susceptibility genes in human IDDM have beenidentified. This paper also showed the availability of the genome-wide search method in human.
   Google Scholar
• BARNETT AH, EFF C, LESLIE RDG et al: Diabetes in iden-tical twins: a study of 200 pairs. Diabetologia (1981) 20:404–409.
   Google Scholar
• MELTON LJ III, PALUMBO PJ, CHU CP et al.: Incidence ofdiabetes mellitus by clinical type. Diabetes Care (1983) 6:75–86.
   PubMedGoogle Scholar
• PATRICK SL, MOY CS, LAPORTE RE: The world ofinsulin-dependent diabetes mellitus: what interna-tional epidemiologic studies reveal about the etiology and natural history of IDDM. Diabetes Metab. Rev. (1989) 5:571–578.
   PubMedGoogle Scholar
• KARVONEN M, TUOMILEHTO J, LIBMAN I et al.: A review of the recent epidemiological data on the worldwide incidence of Type 1 (insulin-dependent) diabetes mel-litus. Diabetologia (1993) 36:883–892.
   PubMed Web of Science ®Google Scholar
• DURON F: Intensive insulin therapy in insulin-dependent diabetes mellitus, the results of the diabetes control and complications trial. Biomed. Pharmacother. (1995) 49:278–82.
   PubMedGoogle Scholar
• EISENBARTH GS: Type I diabetes mellitus: a chronic autoimmune disease. New Engl. J. Med (1986) 314:1360–1368.
   PubMed Web of Science ®Google Scholar
• •Hypothetical stages in the development of autoimmune dia-betes are presented.
   Google Scholar
• YOON JY, AUSTIN M, ONODERA T et al.: Virus-induced diabetes mellitus. Isolation of a virus from the pan-creas of a child with diabetic ketoacidosis. New Engl. J. Med. (1979) 300:1173–1179.
   PubMed Web of Science ®Google Scholar
• YOON JW: The role of viruses and environmental fac-tors in the induction of diabetes. Curr. Top. Microbiol. Immunol. (1990) 164:95–123.
   PubMedGoogle Scholar
• KAUFMAN DL, ERLANDER MG, CLARE-SAIZLER M et al: Autoimmunity to two forms of glutamate decarboxy-lase in insulin-dependent diabetes mellitus. J. Clin. In-vest. (1992) 89:382–392.
   Google Scholar
• HORWITZ MS, BRADLEY LM, HARBERTSON J et al.: Diabe-tes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nature Med. (1998) 4:781–785.
   PubMed Web of Science ®Google Scholar
• BORCH-JOHNSEN K, MANDRUP-POULSEN T, ZACHAU-CHRISTIANSEN B et al: Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. Lancet (1984) 2:1083–1086.
   PubMed Web of Science ®Google Scholar
• MIYAZAKI I, CHEUNG RK, GAEDIGK R et al: T-cell activa-tion and anergy to islet cell antigen in Type 1 diabetes. Immunol (1995) 154:1461–1469.
   Google Scholar
• MAKINO S, TOCHINO Y: The spontaneously non-obese diabetic mouse. Exp. Anim. (1978) 27:27–29.
   Google Scholar
• HATTORI M, BUSE JB, JACKSON RA et al: The NOD mouse: Recessive diabetogenic gene in the major his-tocompatibility complex. Science (1986) 231:733–735.
   PubMed Web of Science ®Google Scholar
• NISHIMOTO H, KIKUTANI H, YAMAMURA K et al: Pre-vention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature (1987) 328:432–434.
   PubMed Web of Science ®Google Scholar
• WICKER LS, APPEL MC, DOTTA F et al: Autoimmune syn-dromes in major histocompatibility complex (MHC) congenic strains of non-obese diabetic (NOD) mice. The MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J. Exp. Med. (1992) 176:67–77.
   PubMed Web of Science ®Google Scholar
• MIYAZAKI T, UNO M, UEHIRA M et al.: Direct evidencefor the contribution of the unique I-A NOD to the devel-opment of insulitis in non-obese diabetic mice. Nature (1990) 345:722–724.
   PubMed Web of Science ®Google Scholar
• LUND T, O'REILLY L, HUTCHINGS P et al.: Prevention ofinsulin-dependent diabetes mellitus in non-obese dia-betic mice by transgenes encoding modified I-A b-chain or normal I-E a-chain. Nature (1990) 345:727–729.
   PubMedGoogle Scholar
• HANAFUSA T, MIYAZAKI A, MIYAGAWA J et al.: Examina-tion of islets in the pancreas biopsy specimens from newly diagnosed Type 1 (insulin-dependent) diabetic patients. Diabetologia (1990) 33:105–11.
   PubMed Web of Science ®Google Scholar
• LO D, BURKLY LC, WIDERA G et al.: Diabetes and toler-ance in transgenic mice expressing class II MHC mole-cules in pancreatic beta-cells. Cell (1988) 53:159–168.
   PubMed Web of Science ®Google Scholar
• PUJOL-BORRELL R, TODD I, DOSHI M et al.: HLA class IIinduction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature (1987) 326:304–306.
   PubMed Web of Science ®Google Scholar
• ITOH N, HANAFUSA T, MIYAZAKI A et al.: Mononuclearcell infiltration and its relation to the expression of major histocompatibility complex antigens and adhe-sion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Invest. (1993) 92:2313–2322.
   PubMed Web of Science ®Google Scholar
• SIGNORE A, POZZILLI P, GALE EA et al.: The natural his-tory of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia (1989) 32:283–289.
   Google Scholar
• BEDOSSA P, BENDELAD A, BACH JF et al.: Syngenic T-cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction. Eur. J. Immunol (1989) 19:1947–1951.
   PubMedGoogle Scholar
• KATZ JD, BENOIST C, MATHIS D et al.: T helper cell sub-sets in insulin-dependent diabetes. Science (1995) 268:1185–1188.
   PubMed Web of Science ®Google Scholar
• VICARI AP, ZLOTNIK A: Mouse NK1.1+ T-cells : a new family of T-cells. Immunol. Today (1996) 17:71–76.
   PubMedGoogle Scholar
• PORCELLI S, YOCKEY CE, BRENNER MB et al.: Analysis of T-cell antigen receptor (TCR) expression by human peripheral blood CD4-8-alpha/beta T-cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J. Exp. Med. (1993) 178:1–16.
   PubMed Web of Science ®Google Scholar
• WILSON SB, KENT SC, PATTON KT et al.: Extreme Thlbias of invariant Vcc24JaQT-cells in Type 1 diabetes. Nature (1998) 391:177–181.
   PubMed Web of Science ®Google Scholar
• YAMAGATA K, NAKAJIMA H, TOMITA K et al.: DominantTCR a-chain clonotypes and interferon-g are ex-pressed in the pancreas of patients with recent-onset insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. (1996) 34:37–46.
   PubMed Web of Science ®Google Scholar
• CONRAD B, WEIDMANN E, TRUCCO G et al: Evidence forsuperantigen involvement in insulin-dependent dia-betes mellitus aetiology. Nature (1994) 371:351–355.
   PubMed Web of Science ®Google Scholar
• CONRAD B, WEISSMAHR RN, BONI J et al.: A human en-dogenous retroviral superantigen as candidate auto-immune gene in Type 1 diabetes. Cell (1997) 90:303–313.
   PubMed Web of Science ®Google Scholar
• MURPHY VJ, HARRISON LC, RUDERT WA et al: Retroviralsuperantigens and Type 1 diabetes mellitus. Cell (1998) 95:9–11.
   PubMedGoogle Scholar
• BOTTAZZO GF, DEAN BM, MCNALLY JM et al: In situcharacterization of autoimmune phenomena and ex-pression of HLA molecules in the pancreas in diabetic insulitis. New Engl. J Med. (1985) 313:353–360.
   PubMed Web of Science ®Google Scholar
• THOMPSON CB: Apoptosis in the pathogenesis and treatment of disease. Science (1995) 267:1456–1462.
   PubMed Web of Science ®Google Scholar
• O'BRIEN BA, HARMON By, CAMERON DP et al.: Apopto-sis is the mode of 13-cell death responsible for the de-velopment of IDDM in the non-obese diabetic (NOD) mouse. Diabetes (1997) 46:750–757.
   PubMed Web of Science ®Google Scholar
• KAGI D, VIGNAUX F, LEDERMANN B et al.: Fas and perfo-rin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (1994) 265:528–530.
   PubMed Web of Science ®Google Scholar
• KAGI D, ODERMATT B, OHASHI PS et al: Developmentof insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. (1996) 183:2143–2152.
   PubMedGoogle Scholar
• CHERVONSKY AV, WANG Y, WONG FS et al.: The role of Fas in autoimmune diabetes. Cell (1997) 89:17–24.
   PubMed Web of Science ®Google Scholar
• ITOH N, IMAGAWA A, HANAFUSA T et al.: Requirement of Fas for the development of autoimmune diabetes in non-obese diabetic mice. J. Exp. Med. (1997) 186:613–618.
   PubMed Web of Science ®Google Scholar
• SIGNORE A, ANNOVAZZI A, GRADINI R et al.: Fas and Fasligand-mediated apoptosis and its role in autoimmune diabetes. Diabetes Metab. Rev. (1998) 14:197–206.
   PubMedGoogle Scholar
• STASSI G, DEMARIA R, TRUCCO G et al. :Nitric oxideprimes pancreatic beta cells for Fas-mediated destruc-tion in insulin-dependent diabetes mellitus. J. Exp. Med (1997) 186:1193–1200.
   PubMed Web of Science ®Google Scholar
• KAUFMAN DL, CLARE-SALZLER M, TIAN J et al.: Spontane-ous loss of T-cell tolerance to glutamic acid decarboxy-lase in murine insulin dependent diabetes. Nature (1993) 366:69–72.
   PubMed Web of Science ®Google Scholar
• TISCH R, YANG XD, SINGER SM et al.: Immune responseto glutamic acid decarboxylase correlates with insuli-tis in non-obese diabetic mice. Nature (1993) 366:72–75.
   PubMed Web of Science ®Google Scholar
• ELLIOTT JF, QIN HY, BHATTI S et al: Immunization with the larger isoform of mouse glutamic acid decarboxy-lase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes (1994) 43:1494–1499.
   PubMed Web of Science ®Google Scholar
• ZHANG ZJ, DAVIDSON L, EISENBARTH G et al: Suppres-sion of diabetes in non-obese diabetic mice by oral ad-ministration of porcine insulin. Proc. Natl. Acad. ScL USA (1991) 88:10252–10256.
   PubMed Web of Science ®Google Scholar
• KELLER RJ, EISENBARTH GS, JACKSON RA: Insulin pro-phylaxis in individuals at high risk of Type 1 diabetes. Lancet (1993) 341:927–928.
   PubMed Web of Science ®Google Scholar
• •Insulin has been suggested as a tool for prevention of hu-man IDDM.
   Google Scholar
• ELIAS D, RESHEF T, BIRK OS et al: Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. ScL USA (1991) 88:3088–3091.
   PubMed Web of Science ®Google Scholar
• ROEP BO, KALLAN AA, HAZENBOS W et al. T-cell reactiv-ity to 38 kDa insulin-secretory granule protein in pa-tients with recent-onset Type 1 diabetes. Lancet (1991) 337 1439–1441
   PubMed Web of Science ®Google Scholar
• RABIN DU, PLEASIC SM, SHAPIRO JA et al: Islet antigen512 is a diabetes-specific islet auto-antigen related to protein tyrosine phosphatases. J. Immunol (1994) 152:3183–3188.
   PubMed Web of Science ®Google Scholar
• SOLIMENA S, DIRKX R, HERMEL JM et al: ICA 512, anauto-antigen of Type 1 diabetes, is an intrinsic mem-brane protein of neurosecretory granules. EMBO J. (1996) 15:2102–2114.
   PubMed Web of Science ®Google Scholar
• RABINOVITCH A, SUAREZ-PINZON WL, SHI Y et al.: DNA fragmentation is an early event in cytokine-induced is-let beta-cell destruction. Diabetologia (1994) 37:733–738.
   PubMed Web of Science ®Google Scholar
• KANETO H, FUJII J, SEO HG et al: Apoptotic cell death triggered by nitric oxide in pancreatic 8-cells. Diabetes (1995) 44:733–738.
   PubMed Web of Science ®Google Scholar
• HOCKENBERY DM, ZUTTER M, HICKEY W et al.: Bc1-2 protein is topographically restricted in tissues charac-terized by apoptotic cell death. Proc. Natl. Acad. ScL USA (1991) 88:6961–6965.
   PubMed Web of Science ®Google Scholar
• IWAHASHI H, HANAFUSA T, EGUCHI Y et al.: Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bc1-2. Diabetologia (1996) 39:530–536.
   PubMedGoogle Scholar
• LIU Y, RABINOVITCH A, SUAREZ-PINZON W et al.: Ex-pression of the bc1-2 gene from a defective HSV-1 am-plicon vector protects pancreatic beta-cells from apoptosis. Hum. Gene Ther. (1996) 7:1719–1726.
   PubMed Web of Science ®Google Scholar
• RILEY WJ, MACLAREN NK, KRISCHER J et al.: A prospec-tive study of the development of diabetes in relatives of patients with insulin dependent diabetes. New Engl. J. Med. (1990) 323:1167–1172.
   PubMed Web of Science ®Google Scholar
• •Demonstration that we may be able to predict disease prog-ress in relatives of patients.
   Google Scholar
• BINGLEY PJ FOR THE ICARUS GROUP: Interactions of age, islet cell antibodies, insulin auto-antibodies, and first-phase insulin response in predicting risk of pro-gression to IDDM in ICA+ relatives. Diabetes (1996) 45:1720–1728.
   PubMedGoogle Scholar
• VERGE CF, GIANANI R, KAWASAKI E et al.: Prediction of Type 1 diabetes in first-degree relatives using a combi-nation of insulin, GAD, and ICA512bdc/IA-2 auto-antibodies. Diabetes (1996) 45:926–933.
   PubMed Web of Science ®Google Scholar
• CAREL JC, BOITARD C, BOUGNERES PF: Decreased insu-lin response to glucose in islet cell antibody negative siblings of Type 1 diabetic children.J. Clin. Invest. (1993) 92:509–513.
   Google Scholar
• SCHATZ D, KRISCHER J, HORNE G et al: Islet cell anti-bodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaf-fected relatives. J. Clin. Invest. (1994) 93:2403–2407.
   PubMed Web of Science ®Google Scholar
• LEVY-MARCHAL C, TICHET J, FAJARDY I et al.: Islet cell antibodies in normal French schoolchildren. Diabe-tologia (1992) 35:577–582.
   PubMedGoogle Scholar
• CAREL JC, LOTTON C, BOUGNERES P et al. Prediction and prevention of Type 1 diabetes: what can be ex-pected from genetics? Diabetes Metab. (1997) 23:29–33.
   Google Scholar
• SHE JX: Susceptibility to Type 1 diabetes: HLA-DQ and DR revisited. Immunol. Today (1996) 17:323–329.
   PubMedGoogle Scholar
• PUGLIESE A, GIANANI R, MOROMISATO R et al.: HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes (1995) 44:608–613.
   PubMedGoogle Scholar
• GERSTEIN H: Does cow's milk cause Type 1 diabetes mellitus? A critical overview of the clinical literature. Diabetes Care (1994) 17:13–19.
   PubMed Web of Science ®Google Scholar
• BODINGTON M, MCNALLY PG, BURDEN AC: Cow's milk and Type 1 childhood diabetes: No increase in risk. Diabetic Med. (1994) 11:663–665.
   PubMedGoogle Scholar
• NORRIS JM, SCOTT FW: A met-analysis of infant diet and insulin-dependent diabetes mellitus: do biases play a role? Epidemiology (1996) 7:87–92.
   PubMed Web of Science ®Google Scholar
• KNIP M, AKERBLOM HK: IDDM prevention trials in progress : a critical assessment. J. Pediatr. Endocrinol. Metab. (1998) 11:371–377.
   PubMedGoogle Scholar
• KARGES W, HAMMOND-MCKIBBEN D, CHEUNG RK et al:Immunological aspects of nutritional diabetes preven-tion in NOD mice: A pilot study for the cow's milk based IDDM prevention trial. Diabetes (1997) 46:557–564.
   PubMed Web of Science ®Google Scholar
• POZZILLI P: BCG vaccine in insulin-dependent diabetes mellitus. Lancet (1997) 349:1520–1521.
   PubMedGoogle Scholar
• STILLER CR, DUPRE J, GENT M et al.: Effects of cyclospor-ine immunosuppression in insulin-dependent diabe-tes mellitus of recent onset. Science (1 9 8 4) 223:1362-1367.
   Google Scholar
• THE CANADIAN/EUROPIAN RANDOMIZED CONTROL TRIAL RESEARCH GROUP Cyclosporin-induced remis-sion of IDDM after early intervention. Association of 1 year of cyclosporin treatment with enhanced insulin secretion. Diabetes (1988) 37:1574–1582.
   PubMedGoogle Scholar
• BOUGNERES PF, LANDAIS P, BOISSON C et al.: Limited duration of remission of insulin-dependencies in chil-dren with recent onset Type 1 diabetes treated with low-dose cyclosporin. Diabetes (1990) 39:1264–1272.
   PubMed Web of Science ®Google Scholar
• CAREL JC, BOITARD C, EISENBARTH G et al.: Cyclosporin delays but does not prevent clinical onset in glucose intolerant pre-Type 1 diabetic children. J. Autoimmun. (1996) 9:739–745.
   PubMedGoogle Scholar
• PIPELEERS D, VAN DE WINKEL M: Pancreatic B-cells pos-sess defence mechanisms against cell-specific toxicity. Proc. Natl. Acad. Sci. USA (1986) 83:5267–5271.
   PubMed Web of Science ®Google Scholar
• KALLMANN B, BURKART V, KRONCKE KD et al.: Toxicity of chemically generated nitric oxide towards pancre-atic islet cell can be prevented by nicotinamide. Life Sci. (1992) 51:671–678.
   PubMed Web of Science ®Google Scholar
• YONEMURA Y, TAKISHIMA T, MIWA K et al.: Ameliora-tion of diabetes mellitus in partially depancreatized rats by poly (ADP-ribose) synthetase inhibitors. Diabe-tes (1984) 33:401–404.
   PubMed Web of Science ®Google Scholar
• EIZIRIK DL, SANDLER S, WELSH N et al.: Nicotinamide de-creases nitric oxide production and partially protects human pancreatic islets against the suppressive ef-fects of combinations of cytokines. Autoimmunity (1994) 19:193–198.
   PubMed Web of Science ®Google Scholar
• ANDRADE J, CONDE M, RAMIREZ R et al.: Protection from nicotinamide inhibition of interleukin-1 beta-induced RN cell nitric oxide formation is associated with induction of MnSOD enzyme activity. Endocrinol-ogy (1996) 137: 4806–4810.
   PubMedGoogle Scholar
• YAMADA K, NONAKA K, HANAFUSA T et al.: Preventionand therapeutic effects of large-dose nicotinamide in-jections on diabetes associated with insulitis: an obser-vation in non-obese diabetic (NOD) mice. Diabetes (1982) 31:749–753.
   PubMed Web of Science ®Google Scholar
• VAGUE PH, VIALETTES B, LASSMAN-VAGUE V et al.: Nicotinamide may extend remission phase in insulin dependent diabetes. Lancet (1987) 1:619–620.
   PubMedGoogle Scholar
• POZZILLI P, BROWNE PD, KOLB H et al: Meta-analysis ofnicotinamide treatment in patients with recent-onset IDDM. Diabetes Care (1996) 19:1357–1363.
   PubMedGoogle Scholar
• GREENBAUM CJ, KAHN SE, PALMER JP: Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM. Diabetes (1996) 45:1631–1634.
   PubMedGoogle Scholar
• POZZILLI P: Prevention of insulin-dependent diabetes: where are we now? Diabetes/Metab Rev. (1996) 12:127–135.
   Google Scholar
• LAMPETER EF, KLINGHAMMER A, SCHERBAUM WA et al.:The Deutsche nicotinamide intervention study. An at-tempt to prevent Type 1 diabetes. Diabetes (1998) 47: 980–984.
   PubMed Web of Science ®Google Scholar
• ELLIOTT RB, PILCHER CC, FERGUSSON DM et al: A popu-lation based strategy to prevent insulin-dependent diabetes using nicotinamide. J. Pediatr. Endocrinol. Me-tab. (1996) 9:501–509.
   PubMed Web of Science ®Google Scholar
• SHAH SC, MALONE JI, SIMPSON NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. New Engl. J. Med. (1989) 320:550–554.
   PubMed Web of Science ®Google Scholar
• VLAHOS WD, SEEMAYER TA, YALE JF: Diabetes preven-tion in BB rats by inhibition of endogenous insulin se-cretion. Metabolism (1991) 40: 825–829.
   PubMed Web of Science ®Google Scholar
• BOWMAN MA, CAMPBELL L, DARROW BL et al: Immuno-logical and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM. Diabetes (1996) 45:205–208.
   PubMed Web of Science ®Google Scholar
• POZZILLI P: Prevention of insulin-dependent diabetes mellitus 1998. Diabetes/Metab Rev. (1998) 14:69–84.
   PubMed Web of Science ®Google Scholar
• SCHERNTHANER G: Progress in the immunointerven-tion of Type-1 diabetes mellitus. Horm. Metab. Res. (1995) 27:547–554.
   PubMedGoogle Scholar
• GROSS DJ, SIDI H, WEISS T et al.: Prevention of diabetesmellitus in non-obese diabetic mice by linomide, a novel immunomodulating drug. Diabetologia (1994) 37:1195–1201.
   PubMed Web of Science ®Google Scholar
• COUTANT R, LANDAIS P, ROSILIO M et al: Low dose li-nomide in Type 1 juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial. Diabetologia (1998) 41:1040–1046.
   PubMed Web of Science ®Google Scholar
• MATHIEU C, WASER M, LAUREY SJ et al: Prevention of autoimmune diabetes in NOD mice by 1, 25-dihydroxyvitamin D3. Diabetologia (1994) 37:552–558.
   PubMed Web of Science ®Google Scholar
• POZZILLI P, VISALLI N, GISELLA M et al.: Vitamin E andnicotinamide have similar effects in maintaining re-sidual beta-cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study). Eur. J. Endo-crinol (1997) 137:234–239.
   PubMed Web of Science ®Google Scholar
• SUTHERLAND DE, GRUESSNER AC, GRUESSNER RW: Pan-creas transplantation: a review. Transplant Proc. (1998) 30:1940–1943.
   PubMedGoogle Scholar
• DUBERNARD JM, TAJRA LCF, LEFRANCOIS N et al.: Pan-creas transplantation: results and indications. Diabetes Metab. (1998) 24:195–199.
   PubMedGoogle Scholar
• BALLINGER WF, LACY PE: Transplantation of intact pancreatic islets in rats. Surgery (1972) 72:175–186.
   PubMed Web of Science ®Google Scholar
• HERING BJ: Insulin independence following islet trans-plantation in man a comparison of different recipient categories. Int. Islet Transpl. Registry (1996) 6:5–19.
   Google Scholar
• BEATTIE GM, OTONKOSKI T, LOPEZ AD et al.: Func-tional B-cell mass after transplantation of human foe-tal pancreatic cells. Diabetes (1997) 46:244–248.
   PubMed Web of Science ®Google Scholar
• WILMUT I, SCHNIEKE AE, MCWHIR J et al.: Viable off-spring derived from foet al and adult mammalian cells. Nature (1997) 385:810–813.
   PubMed Web of Science ®Google Scholar
• ••Cloning techniques has been introduced into mammals.This paper implies a breakthrough in reproductive biology, potential application in transplantation, and also important ethical issues.
   Google Scholar
• WILSON CA, WONG S, MULLER J et al. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J. Vim]. (1998) 72:3082–3087.
   Google Scholar
• WANG S, BEATTIE GM, MALLY MI et al: Isolation and characterization of a cell line from the epithelial cells of the human foet al pancreas. Cell Transplant. (1997) 6:59–67.
   PubMed Web of Science ®Google Scholar
• EFRAT S, FUSCO-DEMANE D, LEMBERG H et al.: Condi-tional transformation of a pancreatic beta-cell line de-rived from transgenic mice expressing a tetracycline-regulated oncogene. Proc. Natl. Acad. ScL USA (1995) 92:3576–3580.
   PubMed Web of Science ®Google Scholar
• CLARK SA, QUAADE C, CONSTANDY H et al.: Novel in-sulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expres-sion. Diabetes (1997) 46:958–967.
   PubMed Web of Science ®Google Scholar
• HOHMEIER HE, BELTRANDELRIO H, CLARK SA et al.: Regulation of insulin secretion from novel engineered insulinoma cell lines. Diabetes (1997) 46:968–977.
   PubMed Web of Science ®Google Scholar
• DENG S, KETCHUM RJ, JUCHER T et al.: Adenoviral trans-fection of canine islet xenografts with immunosup-pressive cytokine genes abrogates primary non-function and prolongs graft survival. Transplant Proc. (1997) 29:770.
   PubMedGoogle Scholar
• PARKER DC, GREINER DL, PHILLIPS NE et al.: Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. ScL USA (1995) 92:9560–9564.
   PubMed Web of Science ®Google Scholar
• LEW AM, BRADY JL, SILVA A et al.: Secretion of CTLA4Ig by an 5V40 T antigen-transformed islet cell line inhib-its graft rejection against the neoantigen. Transplanta-tion (1996) 62:83–89.
   PubMed Web of Science ®Google Scholar
• GAINER AL, SUAREZ-PINZON WL, MIN WP et al.: Im-proved survival of biolistically transfected mouse islet allografts expressing CTLA4Ig or soluble fas ligand. Transplantation (1998) 66:194–199.
   PubMed Web of Science ®Google Scholar
• WEIR GC, BONNER-WEIR S: Scientific and political im-pediments to successful islet transplantation. Diabetes (1997) 46:1247–1256.
   PubMed Web of Science ®Google Scholar
• SUZUKI K, BONNER-WEIR S, TRIVEDI N et al.: Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice. Trans-plantation (1998) 66:21–28.
   Google Scholar
• OBERG-WELSH C, SANDLER S, ANDERSSON A et al.: Ef-fects of vascular endothelial growth factor on pancre-atic duct cell replication and the insulin production of foet al islet-like cell clusters in vitro. Mol Cell Endocri-nol (1997) 126:125–132.
   PubMed Web of Science ®Google Scholar
• WANG RN, REHFELD JF, NIELSEN FC et al.: Expression of gastrin and transforming growth factor-alpha during duct to islet cell differentiation in the pancreas of duct-ligated adult rats. Diabetologia (1997) 46:599–606.
   Google Scholar
• ARNUSH M, GU D, BAUGH C et al.: Growth factors in the regenerating pancreas of gamma-interferon trans-genic mice. Lab. Invest. (1996) 74:985–990.
   PubMedGoogle Scholar
• TERAZONO K, YAMAMOTO H, TAKASAWA S et al.: A novel gene activated in regenerating islets. J. Biol. Chem. (1988) 263:2111–2114.
   PubMed Web of Science ®Google Scholar
• WATANABE T, YONEMURA Y, YONEKURA H et al.: Pan-creatic beta-cell replication and amelioration of surgi-cal diabetes by Reg protein. Proc. Natl. Acad. Sci. USA (1994) 91:3589–3592.
   PubMed Web of Science ®Google Scholar
• MASHIMA H, OHNISHI H, WAKABAYASHI K et al.: Beta-cellulin and activin A co-ordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J. Clin. Invest. (1996) 97:1647–1654.
   PubMed Web of Science ®Google Scholar
• MASHIMA H, SHIBATA H, MINE T et al.: Formation of insulin-producing cells from pancreatic acinar AR42J cells by hepatocyte growth factor. Endocrinology (1996) 137:3969–3976.
   PubMed Web of Science ®Google Scholar
• NIELSEN JH, SERUP P et al.: Molecular basis for islet de-velopment, growth, and regeneration. Curr. Opin. En-docrinol. Diabetes (1998) 5:97–107.
   Google Scholar